支气管扩展剂的反应与控制喘或症状负担在控制不良喘患者中没有关联
David A Kaminsky1, Jiaxian He2, Robert Henderson2
1Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Respiratory medicine
|August 3, 2023
概括
支气管扩展剂反应 (BDR) 与控制不良的喘患者的喘控制或症状无关. 这些发现挑战了BDR在评估喘严重性的临床有用性.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 呼吸系统研究 呼吸系统研究
背景情况:
- 控制喘和症状负担是控制喘的关键指标.
- 支气管扩展反应 (BDR) 常用于评估气道可逆性.
- 在控制不良的喘中BDR的临床实用性需要进一步研究.
研究的目的:
- 评估BDR和喘控制的四个不同定义之间的关联.
- 为了确定BDR和喘症状负担在控制不良的喘之间的关系.
- 评估BDR在一大群控制不良喘患者中的临床相关性.
主要方法:
- 在三项临床试验中分析了931名患有控制不良喘的参与者的数据.
- 评估BDR使用四个不同的定义,基于FEV1和FVC变化后Albuterol.
- BDR与喘控制 (喘控制测试/问卷) 和症状负担 (喘症状实用指数) 的相关性.
主要成果:
- 在31-42%的参与者中观察到BDR,人口群体的流行率各不相同.
- 尽管定义之间有很好的一致性,但只有56%的人符合BDR的四个标准.
- 在对共变量进行调整后,在任何BDR定义和喘控制或症状负担之间没有发现显著的关联.
结论:
- 支气管扩展剂的反应与控制喘或控制不良喘患者的症状负担无关.
- 这些发现质疑BDR在评估这一群体中喘控制和症状的临床实用性.
- 对于有效的喘管理,可能需要替代或额外的标记物.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
307
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
307
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Asthma: Pathogenesis and Management
446
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
446
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
489
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
489
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


